Xiaoping Li
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 5%
- CAR-T cell therapy research
- Drug Transport and Resistance Mechanisms
Papers in
-
- RNA modifications and cancer 11
- Genomics and Phylogenetic Studies 7
- CRISPR and Genetic Engineering 6
- Circular RNAs in diseases 6
- Oncology 38
- Co-authors
- Ezequiel Neimark (3 shared papers)Benjamin L. Shneider (3 shared papers)Jiaming Zhang (1 shared paper)Jia‐Da Li (1 shared paper)Frank Chen (3 shared papers)Xi Zhang (3 shared papers)Yao Liu (1 shared paper)Cheng Zhang (1 shared paper)
- Journals
- Tumor Biology (4 papers)Journal of Biological Chemistry (3 papers)BMC Cancer (3 papers)BMC Nursing (3 papers)Frontiers in Bioengineering and Biotechnology (2 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Xiaoping Li
140 papers receiving 2.8k citations
Xiaoping Li's Hit Papers
Peers
Comparison fields: 5 of 151
- Cancer Research 453
- Oncology 758
- Molecular Biology 1.2k
- Immunology 265
- Geriatrics and Gerontology 49
Countries citing papers authored by Xiaoping Li
This map shows the geographic impact of Xiaoping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Li more than expected).
Fields of papers citing papers by Xiaoping Li
This network shows the impact of papers produced by Xiaoping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Li. The network helps show where Xiaoping Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoping Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 155 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Recent advances in CAR-T cell engineering Hit paper breakdown → | 2020 | 274 |
| 2 | 2004 | 188 | |
| 3 | 2019 | 162 | |
| 4 | 2007 | 114 | |
| 5 | 2003 | 101 | |
| 6 | 2019 | 78 | |
| 7 | 2001 | 71 | |
| 8 | 2013 | 66 | |
| 9 | 2019 | 63 | |
| 10 | 2018 | 62 | |
| 11 | 2019 | 56 | |
| 12 | 2015 | 51 | |
| 13 | 2023 | 49 | |
| 14 | 2002 | 49 | |
| 15 | 2006 | 48 | |
| 16 | 2006 | 48 | |
| 17 | 2017 | 46 | |
| 18 | 2021 | 42 | |
| 19 | 2020 | 42 | |
| 20 | 2011 | 41 |
About Xiaoping Li
Xiaoping Li is a scholar working on Molecular Biology, Oncology, Cancer Research, Surgery and Epidemiology, having authored 155 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (11 papers), MicroRNA in disease regulation (8 papers), Genomics and Phylogenetic Studies (7 papers), CRISPR and Genetic Engineering (6 papers), Circular RNAs in diseases (6 papers), Breast Cancer Treatment Studies (6 papers) and Endometrial and Cervical Cancer Treatments (6 papers). The work is most often cited by research in Cancer Research (453 citations), Oncology (758 citations), Molecular Biology (1.2k citations), Immunology (265 citations) and Geriatrics and Gerontology (49 citations). Xiaoping Li has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Ezequiel Neimark, Benjamin L. Shneider, Jiaming Zhang, Jia‐Da Li, Frank Chen, Xi Zhang, Yao Liu, Cheng Zhang, Jiang F. Zhong and Wen Qin. Their work appears in journals such as Tumor Biology, Journal of Biological Chemistry, BMC Cancer, BMC Nursing and Frontiers in Bioengineering and Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.